These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20391646)

  • 21. Nebulized flunisolide in infants and young children with asthma: a pilot study.
    de Benedictis FM; Martinati LC; Solinas LF; Tuteri G; Boner AL
    Pediatr Pulmonol; 1996 May; 21(5):310-5. PubMed ID: 8726156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asthma and other wheezing disorders of childhood.
    Keeley D; McKean M
    Clin Evid; 2003 Jun; (9):287-317. PubMed ID: 15366138
    [No Abstract]   [Full Text] [Related]  

  • 23. Asthma and other wheezing disorders in infants and children.
    Keeley D; McKean M
    Clin Evid; 2004 Jun; (11):328-59. PubMed ID: 15652008
    [No Abstract]   [Full Text] [Related]  

  • 24. When should your asthmatic patients refill their MDI propelled with chlorofluorocarbons?
    Weinstein AG
    Del Med J; 1998 Jun; 70(6):293-7. PubMed ID: 9662872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; partial final rule for combination drug products containing a bronchodilator. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(188):49276-8. PubMed ID: 11758596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of warmed humidified oxygen combined with nebulized albuterol and ipratropium in pediatric patients with acute exacerbation of asthma in winter months.
    Nibhanipudi K; Hassen GW; Smith A
    J Emerg Med; 2009 Nov; 37(4):446-50. PubMed ID: 19062230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in the air. Banning CFC-driven inhalers could levy a toll on asthma sufferers.
    Harrison E
    Sci Am; 2008 Aug; 299(2):20, 22. PubMed ID: 18666671
    [No Abstract]   [Full Text] [Related]  

  • 28. Financial effect of converting ipratropium-albuterol therapy from inhalers to nebulizer treatments at an academic health system.
    Loborec SM; Johnson SE; Keating EA
    Am J Health Syst Pharm; 2016 Feb; 73(3):121-5. PubMed ID: 26796904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness of the ozone layer and acceptance of a new CFC-free metered dose inhaler among asthmatic patients.
    Liam CK; Lim KH
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):683-9. PubMed ID: 9712285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction.
    Crane J; Gamble S; Purdie G
    N Z Med J; 1987 Jun; 100(826):385-7. PubMed ID: 2967448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of radiolabelled versus unlabelled inhaler formulations.
    Newman SP
    J Aerosol Med; 1996 Mar; 9 Suppl 1():S37-47. PubMed ID: 10160057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of bronchodilator medication in priming a conventional metered dose inhaler: a cost of treating asthma.
    Ross RN
    Med Interface; 1997 Apr; 10(4):141-6. PubMed ID: 10166801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Easing the transition to CFC-free inhalers.
    Legge A
    Community Nurse; 1999 Dec; 5(11):19-20. PubMed ID: 11189650
    [No Abstract]   [Full Text] [Related]  

  • 34. Metered dose pressurized aerosols and the ozone layer.
    Newman SP
    Eur Respir J; 1990 May; 3(5):495-7. PubMed ID: 2198163
    [No Abstract]   [Full Text] [Related]  

  • 35. Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma.
    Allen ED; Whitaker ER; Ryu G
    Pediatr Pulmonol; 1997 Dec; 24(6):397-405. PubMed ID: 9448231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small airway asthma therapy, challenges, and the future.
    Casale TB
    Postgrad Med; 2003 Feb; 113(2 Suppl):15-20. PubMed ID: 19667625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Montreal Protocol and essential use exemptions.
    D'Souza S
    J Aerosol Med; 1995; 8 Suppl 1():S13-7. PubMed ID: 10150490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative taste evaluation of aerosolized formulations of triamcinolone acetonide, flunisolide, and flunisolide with menthol.
    Silvers WS; Cohen R; D'Alonzo G; Fishken D; Lim JC; Stokes AL; McNally CF
    Clin Ther; 1993; 15(6):988-93. PubMed ID: 8111818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Availability and consumption status of CFC and non-CFC inhalers for asthma and chronic obstructive pulmonary diseases in Thailand.
    Bunnag C; Vasanavathana S; Punyaratabandhu P
    Asian Pac J Allergy Immunol; 2006; 24(2-3):85-95. PubMed ID: 17136872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinico-functional evaluation of flunisolide + salbutamol combination (VAL 679/A) vs salbutamol in pediatric patients].
    Guarnaccia S; Pasquali M; Acerbis F; Pedrali M; Duse M; Ugazio AG
    Minerva Pediatr; 1990 Jun; 42(6):237-42. PubMed ID: 2250630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.